These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6134517)

  • 1. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
    Beckmann H; Reynolds GP; Sandler M; Waldmeier P; Lauber J; Riederer P; Gattaz WF
    Arch Psychiatr Nervenkr (1970); 1983; 232(6):463-71. PubMed ID: 6134517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF phenylacetic acid and hostility in paranoid schizophrenia.
    Faull KF; King RJ; Barchas JD; Csernansky JG
    Psychiatry Res; 1989 Nov; 30(2):111-8. PubMed ID: 2616681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid levels of phenylacetic acid in mental illness: behavioral associations and response to neuroleptic treatment.
    Sharma RP; Faull K; Javaid JI; Davis JM
    Acta Psychiatr Scand; 1995 May; 91(5):293-8. PubMed ID: 7639084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary trace amine excretion and platelet monoamine oxidase activity in schizophrenia.
    Yoshimoto S; Kaku H; Shimogawa S; Watanabe A; Nakagawara M; Takahashi R
    Psychiatry Res; 1987 Jul; 21(3):229-36. PubMed ID: 3628609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenylethylamine and monoamine metabolites in CSF of schizophrenics: effects of neuroleptic treatment.
    Beckmann H; Waldmeier P; Lauber J; Gattaz WF
    J Neural Transm; 1983; 57(1-2):103-10. PubMed ID: 6194254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylacetic acid in CSF and serum in Indian schizophrenic patients.
    Davis BA; Shrikhande S; Paralikar VP; Hirsch SR; Durden DA; Boulton AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(1):41-7. PubMed ID: 2008539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of phenylacetic acid in cerebrospinal fluid by gas chromatography-mass spectrometry.
    Kawabata M; Kobayashi K; Shohmori T
    Acta Med Okayama; 1986 Oct; 40(5):271-6. PubMed ID: 3788666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raised cerebrospinal fluid phenylacetic acid concentration: preliminary support for the phenylethylamine hypothesis of schizophrenia?
    Sandler M; Ruthven CR; Goodwin BL; King GS; Pettit BR; Reynolds GP; Tyrer SP; Weller MP; Hirsch SR
    Commun Psychopharmacol; 1978; 2(3):199-202. PubMed ID: 699534
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients.
    Szymanski HV; Naylor EW; Karoum F
    Biol Psychiatry; 1987 Feb; 22(2):194-8. PubMed ID: 3814669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate in schizophrenics and healthy controls.
    Gattaz WF; Gattaz D; Beckmann H
    Arch Psychiatr Nervenkr (1970); 1982; 231(3):221-5. PubMed ID: 6123303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment.
    Widerlöv E; Lindström LH; Besev G; Manberg PJ; Nemeroff CB; Breese GR; Kizer JS; Prange AJ
    Am J Psychiatry; 1982 Sep; 139(9):1122-6. PubMed ID: 6126127
    [No Abstract]   [Full Text] [Related]  

  • 12. CSF monoamine metabolites in schizophrenic patients.
    Gattaz WF; Waldmeier P; Beckmann H
    Acta Psychiatr Scand; 1982 Nov; 66(5):350-60. PubMed ID: 6184954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylethylamine and schizophrenia.
    O'Reilly RL; Davis BA
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jan; 18(1):63-75. PubMed ID: 7906896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-cultural study of a biochemical abnormality in paranoid schizophrenia.
    Jeste DV; Doongaji DR; Panjwani D; Datta M; Potkin SG; Karoum F; Thatte S; Sheth AS; Apte JS; Wyatt RJ
    Psychiatry Res; 1981 Dec; 5(3):341-52. PubMed ID: 6948314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CSF cortisol levels after neuroleptic treatment in schizophrenia.
    Gattaz WF; Hannak D; Beckmann H
    Psychoneuroendocrinology; 1985; 10(3):351-4. PubMed ID: 2865767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylethylamine in paranoid chronic schizophrenia.
    Potkin SG; Karoum F; Chuang LW; Cannon-Spoor HE; Phillips I; Wyatt RJ
    Science; 1979 Oct; 206(4417):470-1. PubMed ID: 504988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoamine neurotransmitter interactions in drug-free and neuroleptic-treated schizophrenics.
    Hsiao JK; Colison J; Bartko JJ; Doran AR; Konicki PE; Potter WZ; Pickar D
    Arch Gen Psychiatry; 1993 Aug; 50(8):606-14. PubMed ID: 7688209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low CSF concentrations of cyclic GMP in schizophrenia.
    Gattaz WF; Cramer H; Beckmann H
    Br J Psychiatry; 1983 Mar; 142():288-91. PubMed ID: 6134562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [beta-Phenylethylamine in the cisternal fluid in acute endogenous psychoses].
    Uebelhack R; Franke L; Seidel K
    Biomed Biochim Acta; 1984; 43(11):1257-60. PubMed ID: 6532460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylethylamine (PEA) and phenylacetic acid (PAA) in the urine of chronic schizophrenic patients and controls.
    Potkin SG; Wyatt RJ; Karoum F
    Psychopharmacol Bull; 1980 Jan; 16(1):52-4. PubMed ID: 7360842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.